https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2022-12-23 / Neuro Oncol 2022 Dec;
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2022-12-23 / Neuro Oncol 2022 Dec;2022-12-23 00:00:002022-12-23 00:00:00Autologous Tumor Lysate-Loaded Dendritic Cell Vaccination (DCVax-L) in glioblastoma: breakthrough or fata morgana?
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2022-12-12 / Front Immunol 2022;13:1080947
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2022-12-12 / Front Immunol 2022;13:10809472022-12-12 00:00:002022-12-12 00:00:00Derivation and external validation of dendritic cell-related gene signatures for predicting prognosis and immunotherapy efficacy in bladder urothelial carcinoma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2022-12-04 / Cancer Med 2023 Mar;12(6):7207-7221
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2022-12-04 / Cancer Med 2023 Mar;12(6):7207-72212022-12-04 00:00:002023-05-30 16:29:12Dendritic cell vaccines improve the glioma microenvironment: Influence, challenges, and future directions
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2022-12-01 / Transl Pediatr 2022 Dec;11(12):2040-2056
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2022-12-01 / Transl Pediatr 2022 Dec;11(12):2040-20562022-12-01 00:00:002024-01-30 11:22:05Immunotherapy for the treatment of pediatric brain tumors: a narrative review
